{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:09:44Z","timestamp":1791230984600,"version":"4.1.0"},"reference-count":57,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004099","name":"La Ligue contre le cancer","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]},{"name":"SIRIC Montpellier Cancer Grant INCa_Inserm_DGOS_12553","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100019486","name":"the Biocodex Microbiota Foundation","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100019486","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,10,24]]},"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      The management of mid and low rectal cancer is based on neoadjuvant chemoradiotherapy (CRT) followed by standardised surgery. There is no biomarker in rectal cancer to aid clinicians in foreseeing treatment response. The determination of factors associated with treatment response might allow the identification of patients who require tailored strategies (eg, therapeutic de-escalation or intensification). Colibactin-producing\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      (CoPEC) has been associated with aggressive colorectal cancer and could be a poor prognostic factor. Currently, no study has evaluated the potential association between intestinal microbiota composition and tumour response to CRT in mid and low rectal cancer. The aim of this study is to assess the association between response to neoadjuvant CRT and faecal intestinal microbiota composition and\/or CoPEC prevalence in patients with mid or low rectal cancer.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a non-randomised bicentric prospective clinical study with a recruitment capacity of 200 patients. Three stool samples will be collected from participants with histological-proven adenocarcinome of mid or low rectum who meet eligibility criteria of the study protocol: one before neoadjuvant treatment start, one in the period between CRT end and surgery and one the day before surgery. In each sample, CoPEC will be detected by culture in special media and molecular (PCR) approaches. The global microbiota composition will be also assessed by the bacterial 16S rRNA gene sequencing. Neoadjuvant CRT response and tumour regression grade will be described using the Dworak system at pathological examination. Clinical data and survival outcomes will also be collected and investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>MICARE was approved by the local ethics committee (Comit\u00e9 de Protection des Personnes Sud-Est II, 18 December 2019. Reference number 2019-A02493-54 and the institutional review board. Patients will be required to provide written informed consent. Results will be published in a peer reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04103567\">NCT04103567<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-061527","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:00:50Z","timestamp":1669971650000},"page":"e061527","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing\n                    <i>Escherichia coli<\/i>\n                    in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct04103567","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04103567","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7401-331X","authenticated-orcid":false,"given":"Christophe","family":"Taoum","sequence":"first","affiliation":[{"name":"Surgical Oncology, Institut r\u00e9gional du Cancer de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Carrier","sequence":"additional","affiliation":[{"name":"Surgical Oncology, Institut r\u00e9gional du Cancer de Montpellier, Montpellier, France"},{"name":"Microbes, Intestin, Inflammation et Susceptibilit\u00e9 de l'H\u00f4te (M2iSH), Clermont Auvergne University, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Jarlier","sequence":"additional","affiliation":[{"name":"Biometrics Unit, Regional Cancer Centre Val d'Aurelle\u2014Paul Lamarque, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenaelle","family":"Roche","sequence":"additional","affiliation":[{"name":"Microbes, Intestin, Inflammation et Susceptibilit\u00e9 de l'H\u00f4te (M2iSH), Clermont Auvergne University, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Gagniere","sequence":"additional","affiliation":[{"name":"Digestive and Hepatobiliary Surgery, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Fiess","sequence":"additional","affiliation":[{"name":"Clinical Research and Innovation Department, Regional Cancer Centre Val d'Aurelle\u2014Paul Lamarque, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"De forges","sequence":"additional","affiliation":[{"name":"Clinical Research and Innovation Department, Regional Cancer Centre Val d'Aurelle\u2014Paul Lamarque, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Chevarin","sequence":"additional","affiliation":[{"name":"Microbes, Intestin, Inflammation et Susceptibilit\u00e9 de l'H\u00f4te (M2iSH), Clermont Auvergne University, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Emmanuel","family":"Colombo","sequence":"additional","affiliation":[{"name":"Surgical Oncology, Institut r\u00e9gional du Cancer de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Barnich","sequence":"additional","affiliation":[{"name":"Microbes, Intestin, Inflammation et Susceptibilit\u00e9 de l'H\u00f4te (M2iSH), Clermont Auvergne University, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rouanet","sequence":"additional","affiliation":[{"name":"Surgical Oncology, Institut r\u00e9gional du Cancer de Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3629-7267","authenticated-orcid":false,"given":"Mathilde","family":"Bonnet","sequence":"additional","affiliation":[{"name":"Microbes, Intestin, Inflammation et Susceptibilit\u00e9 de l'H\u00f4te (M2iSH), Clermont Auvergne University, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"key":"2025121411142198000_12.12.e061527.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"2025121411142198000_12.12.e061527.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040694"},{"key":"2025121411142198000_12.12.e061527.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060829"},{"key":"2025121411142198000_12.12.e061527.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70097-3"},{"key":"2025121411142198000_12.12.e061527.5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/codi.13550","article-title":"Management of rectal cancer: the 2016 French guidelines","volume":"19","author":"Lakkis","year":"2017","journal-title":"Colorectal Dis"},{"key":"2025121411142198000_12.12.e061527.6","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800691019"},{"key":"2025121411142198000_12.12.e061527.7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.9068"},{"key":"2025121411142198000_12.12.e061527.8","first-page":"309","article-title":"Operative versus Nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results","volume":"CXXII","author":"Habr-Gama","year":"2004","journal-title":"Trans Meet Am Surg Assoc"},{"key":"2025121411142198000_12.12.e061527.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00467-2"},{"key":"2025121411142198000_12.12.e061527.10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(17)31056-5","article-title":"Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial","volume":"390","author":"Rullier","year":"2017","journal-title":"Lancet"},{"key":"2025121411142198000_12.12.e061527.11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/DCR.0000000000000849","article-title":"Tailored treatment strategy for locally advanced rectal carcinoma based on the tumor response to induction chemotherapy: preliminary results of the French phase II multicenter GRECCAR4 trial","volume":"60","author":"Rouanet","year":"2017","journal-title":"Dis Colon Rectum"},{"key":"2025121411142198000_12.12.e061527.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00079-6"},{"key":"2025121411142198000_12.12.e061527.13","doi-asserted-by":"publisher","DOI":"10.1007\/s003840050072"},{"key":"2025121411142198000_12.12.e061527.14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.8376"},{"key":"2025121411142198000_12.12.e061527.15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.6049"},{"key":"2025121411142198000_12.12.e061527.16","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13121361"},{"key":"2025121411142198000_12.12.e061527.17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.diii.2016.08.012","article-title":"Restaging rectal cancer after neoadjuvant treatment with multiparametric MRI: a landscape of new opportunities","volume":"97","author":"Nougaret","year":"2016","journal-title":"Diagn Interv Imaging"},{"key":"2025121411142198000_12.12.e061527.18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1148\/rg.2019180075","article-title":"Mri evaluation of the response of rectal cancer to neoadjuvant chemoradiation therapy","volume":"39","author":"Kalisz","year":"2019","journal-title":"Radiographics"},{"key":"2025121411142198000_12.12.e061527.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-185X.2012.00218.x"},{"key":"2025121411142198000_12.12.e061527.20","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt300"},{"key":"2025121411142198000_12.12.e061527.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70186-8"},{"key":"2025121411142198000_12.12.e061527.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70194-5"},{"key":"2025121411142198000_12.12.e061527.23","doi-asserted-by":"publisher","DOI":"10.4161\/gmic.24220"},{"key":"2025121411142198000_12.12.e061527.24","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(03)00049-2"},{"key":"2025121411142198000_12.12.e061527.25","doi-asserted-by":"publisher","DOI":"10.1126\/science.1127059"},{"key":"2025121411142198000_12.12.e061527.26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1001261107"},{"key":"2025121411142198000_12.12.e061527.27","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar7785"},{"key":"2025121411142198000_12.12.e061527.28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056964"},{"key":"2025121411142198000_12.12.e061527.29","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1343"},{"key":"2025121411142198000_12.12.e061527.30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5724"},{"key":"2025121411142198000_12.12.e061527.31","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305257"},{"key":"2025121411142198000_12.12.e061527.32","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah3648"},{"key":"2025121411142198000_12.12.e061527.33","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1053\/j.gastro.2019.12.026","article-title":"Autophagy of intestinal epithelial cells inhibits colorectal carcinogenesis induced by Colibactin-Producing Escherichia coli in ApcMin\/+Mice","volume":"158","author":"Lucas","year":"2020","journal-title":"Gastroenterology"},{"key":"2025121411142198000_12.12.e061527.34","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-3472"},{"key":"2025121411142198000_12.12.e061527.35","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-0985-4"},{"key":"2025121411142198000_12.12.e061527.36","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32920"},{"key":"2025121411142198000_12.12.e061527.37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184584","article-title":"Intestinal microbiota: a novel target to improve anti-tumor treatment?","volume":"20","author":"Vill\u00e9ger","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025121411142198000_12.12.e061527.38","doi-asserted-by":"publisher","DOI":"10.4161\/gmic.28932"},{"key":"2025121411142198000_12.12.e061527.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2017.01.152"},{"key":"2025121411142198000_12.12.e061527.40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.07.010"},{"key":"2025121411142198000_12.12.e061527.41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1042\/CS20160876","article-title":"Interactions between microsatellite instability and human gut colonization by Escherichia coli in colorectal cancer","volume":"131","author":"Gagni\u00e8re","year":"2017","journal-title":"Clin Sci"},{"key":"2025121411142198000_12.12.e061527.42","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i2.501"},{"key":"2025121411142198000_12.12.e061527.43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1599"},{"key":"2025121411142198000_12.12.e061527.44","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31011"},{"key":"2025121411142198000_12.12.e061527.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.03.010"},{"key":"2025121411142198000_12.12.e061527.46","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.14.779"},{"key":"2025121411142198000_12.12.e061527.47","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1158\/1078-0432.CCR-19-0960","article-title":"Microbiota- and radiotherapy-induced gastrointestinal side-effects (MARS) study: a large pilot study of the microbiome in acute and late radiation enteropathy","volume":"25","author":"Reis Ferreira","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2025121411142198000_12.12.e061527.48","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-313789"},{"key":"2025121411142198000_12.12.e061527.49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082659"},{"key":"2025121411142198000_12.12.e061527.50","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3449-4","article-title":"Study protocol: multi-parametric magnetic resonance imaging for therapeutic response prediction in rectal cancer","volume":"17","author":"Pham","year":"2017","journal-title":"BMC Cancer"},{"key":"2025121411142198000_12.12.e061527.51","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/annonc\/mdx293","article-title":"Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling","volume":"28","author":"Gon\u00e7alves-Ribeiro","year":"2017","journal-title":"Ann Oncol"},{"key":"2025121411142198000_12.12.e061527.52","first-page":"1062","article-title":"Correlation between tumor microenvironment-associated factors and the efficacy and prognosis of neoadjuvant therapy for rectal cancer","volume":"17","author":"Zhang","year":"2019","journal-title":"Oncol Lett"},{"key":"2025121411142198000_12.12.e061527.53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fmolb.2014.00024","article-title":"Biological response of cancer cells to radiation treatment","volume":"1","author":"Baskar","year":"2014","journal-title":"Front Mol Biosci"},{"key":"2025121411142198000_12.12.e061527.54","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.56"},{"key":"2025121411142198000_12.12.e061527.55","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2019.1639302"},{"key":"2025121411142198000_12.12.e061527.56","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","article-title":"Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell"},{"key":"2025121411142198000_12.12.e061527.57","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3958"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-061527","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T19:14:33Z","timestamp":1765739673000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-061527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,2]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/bmjopen-2022-061527"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-061527","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}